União Europeia - tcheco - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplasmy prsů - antineoplastická činidla - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

União Europeia - tcheco - EMA (European Medicines Agency)

astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastická činidla - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.

República Tcheca - tcheco - SUKL (Státní ústav pro kontrolu léčiv)

zentiva, k.s., praha array - 16475 ambrisentan - potahovaná tableta - 10mg - ambrisentan

República Tcheca - tcheco - SUKL (Státní ústav pro kontrolu léčiv)

zentiva, k.s., praha array - 16475 ambrisentan - potahovaná tableta - 5mg - ambrisentan

República Tcheca - tcheco - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

ecuphar nv - meloxikam - Žvýkací tableta - oxicams - psi

República Tcheca - tcheco - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

ecuphar nv - meloxikam - Žvýkací tableta - oxicams - psi

União Europeia - tcheco - EMA (European Medicines Agency)

ratiopharm gmbh - desloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminika pro systémové použití, - desloratadine ratiopharm is indicated in adults for the relief of symptoms associated with:allergic rhinitischronic idiopathic urticaria as initially diagnosed by a physician.

República Tcheca - tcheco - SUKL (Státní ústav pro kontrolu léčiv)

g.l. pharma gmbh, lannach array - 41 monohydrÁt sitagliptin-hydrochloridu - potahovaná tableta - 100mg - sitagliptin

República Tcheca - tcheco - SUKL (Státní ústav pro kontrolu léčiv)

g.l. pharma gmbh, lannach rakousko - 41 monohydrÁt sitagliptin-hydrochloridu - potahovaná tableta - 25mg - sitagliptin

República Tcheca - tcheco - SUKL (Státní ústav pro kontrolu léčiv)

g.l. pharma gmbh, lannach rakousko - 41 monohydrÁt sitagliptin-hydrochloridu - potahovaná tableta - 50mg - sitagliptin